Neuroscience has long been a frontier for exploring the intricate workings of the human brain. Recent advances in technology have propelled this field into an era of unprecedented discovery, enabling researchers and medical professionals to make progress in treating and curing conditions and diseases. Behind the scenes of breakthrough treatments and drugs are countless hours of research and studies conducted by doctors and scientists. This field does not see many young people, especially young women, who are able to make meaningful contributions quickly and build rapport among their peers.

Hanna Aliashkevich, a neurosurgeon and a pioneer in neurobiology from Minsk, Belarus, has conducted extensive research on the topic of high-grade glioma antiviral treatment. This particular topic has never been fully explored in the field of neuroscience, and it still leaves a lot to be studied further. Her findings were first presented at the Young Neurosurgeons Meeting, powered by the European Association of Neurosurgical Societies, in 2018 in Oxford, United Kingdom. Hanna found that inflammation in the glial brain tumors contaminated by the Herpes Simplex virus activates the tumor cells' rapid multiplication. This discovery is truly a breakthrough in neurology, as it paves the way for medical professionals to study treatment options. The data Hanna studied showed that doctors are able to increase glioblastoma patient survival rate by 25% over five years. These findings are vital to the advancement of new therapies that can be shared with the world. "At the core of my vision is a commitment to advancing our understanding and treatment of brain cancer, particularly high-grade gliomas. I am dedicated to contributing my knowledge and skills by uncovering novel insights into the pathogenesis and treatment of these challenging diseases. Through my work, I aim to push the boundaries of current research and pave the way to improve patient outcomes and quality of life," says Hanna.

These studies also open the doors for other professionals to expand on the research and offer new and innovative solutions in technology. This and other findings that Dr. Hanna has presented were peer-reviewed and published in several professional periodicals and presented at medical conferences. Despite her young age, Hanna Aliashkevich was already presented as a first author in the Neurology and Neurosurgery Eastern Europe International Scientific Journal and other notable, peer-reviewed publications. She is respected by fellow medical professionals for her significant contributions and original research in the field of neuroscience, specifically the study of the effects of the Herpes Simplex Virus. 

"I remember that I have dreamt of being a doctor since I was a kid. During my college years I enjoyed taking different courses, from ophthalmology to anesthesiology. I applied for all the student conferences that were offered at the time. Back then neurosurgery seemed like something impossible, like flying to the moon, but by the time I graduated I was already offered a job, and everything since then was history."

Today, Hanna brings over ten years of experience and influence in the clinical setting to R3 Biotechnologies, a company specializing in brain research. She has joined a team of researchers, bringing her past contributions and knowledge to propel the availability of treatment options. Her colleagues regard her work as one of the most progressive among young professionals, and this is not without reason. In addition to neuro-oncology, Dr. Aliashkevich has previously studied and specialized in spine neurosurgery, facial paralysis surgery, and cranioplasty /reconstructive neurosurgery. "My goal is to conduct further studies which will allow us to uncover new treatments and advance patient care strategies on a global scale, by leveraging emerging technologies. Collaboration with my peers and other fellow members of the medical community, including those from other disciplines, is the most efficient way this can be achieved."

Aliashkevich's dedication to her work is further evidenced by her esteemed memberships in various prestigious organizations, including the European Association of Neurosurgical Societies (EANS), where she served as an Individual Membership Committee member for two years, American Association of Neurological Surgeons (AANS), Congress of Neurological Surgeons (CNS), Association for Women in Science (AWIS), as well as Women in Neurosurgery (WINS) which highlights her commitment to diversity and inclusion in the medical community. In a field where the stakes are high, and challenges are immense, Dr.Aliashkevich continues to be a dedicated professional whose contributions lay the groundwork for a better future.